ENDRA Life Sciences Inc. (NDRA) Social Stream
ENDRA LIFE SCIENCES INC (NDRA) Price Targets From Analysts
Use the tables below to see what analysts covering ENDRA LIFE SCIENCES INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 15, 2022
The Trend in the Analyst Price Target
NDRA's average price target has moved up $94.83 over the prior 22 months.
NDRA reports an average of 11,467.52% for its upside potential over the past 32 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NDRA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
NDRA's average broker recommendation rating improved by 0 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ENDRA LIFE SCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than just about none of of that group.
- In the context of all US stocks, ENDRA LIFE SCIENCES INC's variance in analysts' estimates is lower than just about 100% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, ENDRA LIFE SCIENCES INC's average analyst price target is higher than 94.35% of them.
- In the context of stocks in the micro market cap category, ENDRA LIFE SCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 152.97% of them.
In the Medical Equipment industry, BSGM, SLNO, and ELMD are the three stocks most similar to ENDRA LIFE SCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NDRA a Buy, Hold or Sell? See the POWR Ratings now!